NWPF

News ArchivesRead News

Beauty treatment gives relief to Parkinson’s patients

Thursday April 29, 2010

Health News - One of the world’s most fashionable beauty treatments is gaining popularity for something other than the war on wrinkles.

Botulinum Toxin, commonly known as Botox, is being used at the Muhammad Ali Parkinson Centre (MAPC) at Barrow Neurological Institute to help manage symptoms associated with Parkinson’s disease and other movement disorders.

“Botox is the most powerful nerve toxin known to man and it’s dramatically improving the quality of life for people with Parkinson’s,” says Guillermo Moguel-Cobos, movement disorder neurologist at the Centre. “For this type of treatment, it’s a miracle drug.”

Parkinson’s disease is characterised by muscle rigidity, tremors, a slowing of physical movement and a loss of physical movement.

Botox, which has been purified and then diluted, can be injectedstraight into the muscle, relieving the spasms and most importantly, the pain.

“It’s a medical treatment but it’s also an art to administer. Every patient receives Botox differently in different muscles, in different locations and in different dosages, so experience with the drug and the disease is crucial,” says Moguel-Cobos.

MAPC has been using Botox to treat Parkinson’s and other movement disorders such as dystonia since the early 1990s.

The treatment has recently gained popularity due to the growing number of patients at the MAPC. Out of approximately 1,600 patient visits each year, 30 percent receive Botox injections.

To help with the demand, the Centre runs a Botox Clinic two days a week. Depending on the patient and the severity of their movement disorder, their Botox can take 30 minutes to an hour to inject and can take up to seven days to become effective.

For most, the drug will provide significant but variable relief of symptoms that can last up to three months, says a release from the Barrow Neurological Institute.

Recent News

Aug 24 - Study Details Process Involved in Parkinson’s Disease
Aug 20 - Two proteins work together to help cells eliminate trash; Parkinson's may result
Aug 17 - Scientists visualize critical part of basal ganglia pathways
Aug 17 - VA benefits office seeks all vets exposed to Agent Orange
Aug 12 - New, rapid dementia screening tool rivals 'gold standard' clinical evaluations
Aug 11 - Strolling in Seaside, fighting Parkinson's
Aug 11 - Scientists probing molecular origins of Parkinson's disease highlight two proteins
Aug 11 - Could Chocolate Help To Ease Parkinson’s Disease?
Aug 10 - Take 2: Why Seattle should try to replicate Spokane’s 3-on-3 Hoopfest success
Aug 10 - Book Review: A voyage into Parkinson’s disease, led by patient and journalist
Aug 10 - Parkinson's could be slowed with existing drug
Aug 7 - Opinion: Why modern life is making dementia in your 40s more likely
Aug 3 - Software Turns Smartphones into Tools for Medical Research
Jul 31 - Innovative Technology Using Dragonflies Might Offer Insights Into Human Brain Function
Jul 27 - Low-dose lithium reduces side effects from most common treatment for Parkinson's disease
Jul 27 - Opinion: Parkinson's disease creating class of workers who fear for their jobs: PennLive letters
Jul 22 - Parkinson's: Diabetes drug may offer clue to treatment
Jul 19 - Alzheimer's Drugs in the Works Might Treat Other Diseases, Too
Jul 17 - Parkinson's disease may be treatable with antimalaria drugs
Jul 16 - Virtual research studies feasible